BCAS1 (brain enriched myelin associated protein 1) functions as a marker of immature, actively myelinating oligodendrocytes during both development and remyelination processes 1. The protein identifies oligodendrocyte lineage cells in the stage of active myelin formation, with expression levels being high in newly formed pre-myelinating oligodendrocytes but reduced in mature oligodendrocytes 2. BCAS1-positive oligodendrocytes can shift from a quiescent to an activated, internode-forming morphology when responding to demyelinating injuries, co-expressing myelin-associated glycoprotein (MAG) necessary for axonal contact formation 1. In multiple sclerosis, BCAS1-positive oligodendrocytes represent a population of pre-differentiated cells that rapidly respond to demyelinating insults, enabling immediate myelin regeneration 1. However, impaired maturation of early-stage BCAS1-positive oligodendrocytes correlates with inflammatory microglia and remyelination deficits 3. The protein is also expressed in perineuronal satellite oligodendrocytes that contribute to cortical remyelination 1. Disease relevance extends beyond demyelinating conditions, as BCAS1 expression is altered in various pathological states including stroke 2, multiple system atrophy 4, and gliomas 5, suggesting broader roles in oligodendrocyte biology and CNS pathology.